Research graph
References from Independent validation of circulating microRNAs as biomarkers in a case-control study of adolescents with type 1 diabetes for more than 8 years. Local targets link to admitted publications; unresolved targets remain external evidence.
The pathogenic “symphony” in type 1 diabetes: A disorder of the immune system, β cells, and exocrine pancreas
10.1016/j.cmet.2023.06.018 · 2023 · External reference
Immune Mechanisms and Pathways Targeted in Type 1 Diabetes
10.1007/s11892-018-1066-5 · 2018 · External reference
Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association
10.2337/dc15-1419 · 2015 · External reference
The challenge of modulating β-cell autoimmunity in type 1 diabetes
10.1016/s2213-8587(18)30112-8 · 2019 · External reference
Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes
10.2337/dc19-0880 · 2020 · External reference
MicroRNA Signatures as Future Biomarkers for Diagnosis of Diabetes States
10.3390/cells8121533 · 2019 · External reference
The importance of biomarker development for monitoring type 1 diabetes progression rate and therapeutic responsiveness
10.3389/fimmu.2023.1158278 · 2023 · External reference
Plasma proteomics in children with new-onset type 1 diabetes identifies new potential biomarkers of partial remission
10.1038/s41598-024-71717-4 · 2024 · External reference
Predicting Postoperative Liver Dysfunction Based on Blood-Derived MicroRNA Signatures
10.1002/hep.30572 · 2019 · External reference
Circulating microRNAs in young individuals with long-duration type 1 diabetes in comparison with healthy controls
10.1038/s41598-023-38615-7 · 2023 · External reference
Circulating serum and plasma levels of micro-RNA in type-1 diabetes in children and adolescents: A systematic review and meta-analysis
10.1111/eci.13510 · 2021 · External reference
Altered MicroRNA Profile in Osteoporosis Caused by Impaired WNT Signaling
10.1210/jc.2017-02585 · 2018 · External reference
Circulating microRNA Signatures in Patients With Idiopathic and Postmenopausal Osteoporosis and Fragility Fractures
10.1210/jc.2016-2365 · 2016 · External reference
Unique, Gender-Dependent Serum microRNA Profile in PLS3 Gene-Related Osteoporosis
10.1002/jbmr.4097 · 2020 · External reference
SVF-derived extracellular vesicles carry characteristic miRNAs in lipedema
10.1038/s41598-020-64215-w · 2020 · External reference
ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap
10.1093/nar/gkv468 · 2015 · External reference
Distribution of miRNA expression across human tissues
10.1093/nar/gkw116 · 2016 · External reference
MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases
10.1136/gutjnl-2020-322526 · 2021 · External reference
Increased plasma levels of miR-124-3p, miR-125b-5p and miR-192-5p are associated with outcomes in acute ischaemic stroke patients receiving thrombolysis
10.1016/j.atherosclerosis.2019.08.002 · 2019 · External reference
Validation of differentially expressed brain-enriched microRNAs in the plasma of PD patients
10.1002/acn3.51146 · 2020 · External reference
Elevated Acute Plasma miR-124-3p Level Relates to Evolution of Larger Cortical Lesion Area after Traumatic Brain Injury
10.1016/j.neuroscience.2020.02.045 · 2020 · External reference
Overexpression of miR-595 and miR-1246 in the sera of patients with active forms of inflammatory bowel disease
10.1097/mib.0000000000000285 · 2015 · External reference
miR-21 and miR-146a: The microRNAs of inflammaging and age-related diseases
10.1016/j.arr.2021.101374 · 2021 · External reference
Circulating microRNAs as clinically useful biomarkers for Type 2 Diabetes Mellitus: miRNomics from bench to bedside
10.1016/j.trsl.2022.03.008 · 2022 · External reference
MiR-135a promotes renal fibrosis in diabetic nephropathy by regulating TRPC1
10.1007/s00125-014-3282-0 · 2014 · External reference
Inhibition of miRNA‑135a‑5p ameliorates TGF‑β1‑induced human renal fibrosis by targeting SIRT1 in diabetic nephropathy
10.3892/ijmm.2020.4647 · 2020 · External reference
Identification of miRNAs Involved in Reprogramming Acinar Cells into Insulin Producing Cells
10.1371/journal.pone.0145116 · 2015 · External reference
The Relation between the Cancer and Diabetes Death-rates
10.1017/s0022172400005702 · 1914 · External reference
Higher Incidence of Diabetes in Cancer Patients Compared to Cancer-Free Population Controls: A Systematic Review and Meta-Analysis
10.3390/cancers14071808 · 2022 · External reference
Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records
10.1016/s2213-8587(20)30431-9 · 2021 · External reference
Cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation
10.2337/dc14-1996 · 2015 · External reference
Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals
10.1007/s00125-016-3884-9 · 2016 · External reference
MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapy
10.20892/j.issn.2095-3941.2020.0033 · 2020 · External reference
MicroRNAs and other non-coding RNAs as targets for anticancer drug development
10.1038/nrd4140 · 2013 · External reference
Identifying the differentially expressed microRNAs in autoimmunity: A systemic review and meta-analysis
10.1080/08916934.2019.1710135 · 2020 · External reference
Noncoding RNAs in Cardiovascular Disease: Pathological Relevance and Emerging Role as Biomarkers and Therapeutics
10.1093/ajh/hpx197 · 2018 · External reference
MiR-223-3p in Cancer Development and Cancer Drug Resistance: Same Coin, Different Faces
10.3390/ijms25158191 · 2024 · External reference
Targeting the microRNA-34a as a Novel Therapeutic Strategy for Cardiovascular Diseases
10.3389/fcvm.2021.784044 · 2022 · External reference
Functional role of miR-34a in diabetes and frailty
10.3389/fragi.2022.949924 · 2022 · External reference
Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression
2012 · External reference
Diabetes-associated microRNAs in pediatric patients with type 1 diabetes mellitus: a cross-sectional cohort study
10.1210/jc.2013-3868 · 2014 · External reference
Comparing the MicroRNA spectrum between serum and plasma
10.1371/journal.pone.0041561 · 2012 · External reference
Circulating miRNAs in bone health and disease
10.1016/j.bone.2020.115787 · 2021 · External reference
